Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Titration, Taper Coach & Side Effects Plan your titration schedule with dose-increase reminders, and step down with Taper Coach guidance and warnings
Current Marketed Therapies Novo Nordisks portfolio is anchored by semaglutide (Ozempic, Wegovy, Rybelsus), while Eli Lillys leading product is tirzepatide (Mounjaro, Zepbound)
PlexusDx Precision Peptide Genetic Test ($298) analyzes other pathways that influence how your body responds to GLP-1 signaling and gastric motility
When using Ozempic or Rybelsus tablets concomitantly with other oral drugs that have a narrow therapeutic index or that require clinical monitoring, consider increased clinical or laboratory monitoring Use in Specific Populations Pregnancy: Available data with semaglutide use in pregnant women are not sufficient to determine a drug associated risk for major birth defects, miscarriage, or other adverse maternal or fetal outcomes
